RAYMOND JAMES & ASSOCIATES - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 159 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$850,000
+11.0%
33,149
+3.0%
0.00%0.0%
Q2 2022$766,000
-58.3%
32,198
-54.2%
0.00%
-50.0%
Q4 2020$1,838,000
+33.4%
70,264
-11.2%
0.00%0.0%
Q3 2020$1,378,000
-6.7%
79,166
-9.9%
0.00%0.0%
Q2 2020$1,477,000
+11.4%
87,831
-21.3%
0.00%0.0%
Q1 2020$1,326,000
-44.6%
111,532
-43.6%
0.00%
-33.3%
Q4 2019$2,392,000
+0.2%
197,664
+17.1%
0.00%0.0%
Q3 2019$2,387,000
+22.9%
168,857
-3.1%
0.00%0.0%
Q2 2019$1,943,000
+31.6%
174,259
+38.5%
0.00%
+50.0%
Q1 2019$1,477,000
-39.4%
125,781
-31.1%
0.00%
-50.0%
Q4 2018$2,438,000
+152.1%
182,520
+164.6%
0.00%
+300.0%
Q3 2018$967,000
+23.8%
68,977
+38.9%
0.00%0.0%
Q2 2018$781,000
+14.7%
49,670
+20.1%
0.00%0.0%
Q1 2018$681,000
-5.4%
41,368
+3.8%
0.00%0.0%
Q4 2017$720,000
-60.6%
39,863
-57.9%
0.00%
-75.0%
Q3 2017$1,829,000
+76.0%
94,748
+7.6%
0.00%
+100.0%
Q2 2017$1,039,000
+108.6%
88,028
+93.9%
0.00%
+100.0%
Q1 2017$498,00045,4000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders